Bharat Immunologicals & Biologicals Corporation Profit & Loss Annual

Trade
BSE: 524663 | NSE: - | ISIN: INE994B01014 | Sector: Major Drugs
23.63 +0.01 (0.04%)Updated : 25 Nov 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 44.6178.3985.3366.84
Total Revenue 44.6178.3985.3366.84
Costof Revenue Total 54.3173.4895.6667.34
Gross Profit -9.704.91-10.33-0.50
Depreciation/ Amortization 0.150.210.240.24
Other Operating Expenses Total 8.779.8910.559.91
Total Operating Expense 63.2283.59106.4477.48
Operating Income -18.61-5.20-21.11-10.65
Interest Inc( Exp) Net- Non- Op Total -70.41-50.97-43.53-40.52
Other Net 2.800.611.250.49
Net Income Before Taxes -22.85-9.69-24.21-14.20
Provisionfor Income Taxes -5.79-0.93-6.10-3.99
Net Income After Taxes -17.06-8.75-18.11-10.21
Net Income Before Extra Items -17.06-8.75-18.11-10.21
Net Income -17.06-8.75-18.11-10.21
Income Availableto Com Excl Extra Ord -17.06-8.75-18.11-10.21
Income Availableto Com Incl Extra Ord -17.06-8.75-18.11-10.21
Diluted Net Income -17.06-8.75-18.11-10.21
Diluted Weighted Average Shares 4.324.324.324.32
Diluted EPS Excluding Extra Ord Items -3.95-2.03-4.19-2.36
Diluted Normalized EPS -3.95-2.03-4.19-2.36
Total Adjustmentsto Net Income --0.00-
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts